President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Solid Tumor.

Climate transition, geopolitical dynamics, and technological advancement continue to reshape the investment landscape. Taking ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Even before Trump enters the White House, the planet is showing worrying vital signs with scientists virtually certain 2024 ...